
ASTH Stock Forecast & Price Target
ASTH Analyst Ratings
Bulls say
Astrana Health is positioned for success due to its strong partnerships, efficient coding and technology, and expected increase in Medicare reimbursement. However, competition, potential setbacks from Medicaid, and risks associated with full-risk conversion may impact the company's growth in the future.
Bears say
Astrana Health is in the healthcare industry in the United States and operates in an attractive market of value-based care, providing coordinated, outcomes-based medical care for patients with multiple chronic conditions. However, the company faces risks with its reliance on a few key segments for the majority of its revenue, potential increases in healthcare costs, and uncertain regulatory and political landscapes. Furthermore, ASTH may face significant upfront costs and challenges with implementing new clients and integrating acquired businesses. These factors, combined with the company's young age and significant losses, contribute to a negative outlook on the stock.
This aggregate rating is based on analysts' research of Astrana Health Inc and is not a guaranteed prediction by Public.com or investment advice.
ASTH Analyst Forecast & Price Prediction
Start investing in ASTH
Order type
Buy in
Order amount
Est. shares
0 shares